Pervasis Therapeutics is a clinical stage company developing a broad portfolio of biologically active therapeutics. Building on its deep understanding of the specialized role that the endothelium plays in regulating natural healing and repair processes associated with disease, Pervasis is advancing groundbreaking new therapies to dramatically improve the outcomes of common vascular interventions, such as arteriovenous access, angioplasties, stents, and peripheral and coronary bypass grafts â€“ the failure of which result in serious complications and a significant increase in medical costs.
Past Team (2)Update
Funding Rounds (3) - $44.5MUpdate
Global Venture Capital Firm
Polaris Partners is a venture company investing in digital media, life sciences, and enterprise...
Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates...
Musket Research Associates is an investment banking firm specializing in healthcare. It was...
One Kendall Square, Ste. B6101
Cambridge, MA 02139